Recent advances - HIV infection .1.

[1] *ABB LAB, 1996, NORV RIT CAPS OR SOL

[2] BEISER C, IN PRESS BMJ

[3] BRUNVEZINET F, 1996, 11 INT C AIDS VANC

[4] CAMERON DW, 1996, 11 INT C AIDS VANC

[5] CAMERON W, 1996, 11 INT C AIDS VANC

[6] Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02): : 146 - 154

[7] CARR A, 1996, 11 INT C AIDS VANC

[8] *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P468

[9] *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P929

[10] CD4+ LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION TAKING ZIDOVUDINE [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) : 674 - 680

[1] *ABB LAB, 1996, NORV RIT CAPS OR SOL

[2] BEISER C, IN PRESS BMJ

[3] BRUNVEZINET F, 1996, 11 INT C AIDS VANC

[4] CAMERON DW, 1996, 11 INT C AIDS VANC

[5] CAMERON W, 1996, 11 INT C AIDS VANC

[6] Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02): : 146 - 154

[7] CARR A, 1996, 11 INT C AIDS VANC

[8] *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P468

[9] *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P929

[10] CD4+ LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION TAKING ZIDOVUDINE [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) : 674 - 680